Mounjaro side effects: what the BNF and clinical guidance actually say

What does the BNF actually list as Mounjaro side effects?

The BNF entry for tirzepatide draws on the medicine's Summary of Product Characteristics (SmPC), which in turn reflects data from the SURMOUNT clinical programme. The adverse-effects listed there fall into a clear hierarchy. Very common effects (affecting more than one in ten people) are almost all gastrointestinal: nausea, vomiting, diarrhoea, constipation, and indigestion or reflux. These dominate the profile because tirzepatide slows gastric emptying as part of how it works, and the gut takes time to adapt.

Common effects (one in ten to one in a hundred) include burping, abdominal pain, fatigue, dizziness, and injection-site reactions such as redness or itching. Hair thinning (alopecia) appears in this bracket too, though it typically reflects the metabolic shift of significant weight loss rather than a direct drug toxicity.

Less common but more serious entries in the BNF-referenced profile include acute pancreatitis, gallbladder disease, and hypersensitivity reactions. These are infrequent, but they are the reason clinical review matters before and during treatment. You can read the full listing on the BNF's tirzepatide page or in the detailed Mounjaro SmPC on the eMC, which is the canonical source prescribers reference.

The practical takeaway: the BNF categorises effects by frequency, not by how noticeable they feel day to day. Nausea may be listed as "very common" and still be entirely manageable for most people who take it steadily.

When do side effects tend to appear, and do they go away?

Timing matters a great deal with Mounjaro. Gastrointestinal effects are most noticeable in two windows: the first few weeks of starting treatment, and the days following each dose increase. The prescribing strategy of beginning at 2.5 mg (a dose chosen for tolerability, not its weight-management effect) exists precisely to let the body adjust gradually before the dose moves upward.

For most people, nausea and loose stools settle within a week or two of a new dose level, and our guide to what happens if side effects occur explains the steps you can take during that window. Eating smaller meals, staying well hydrated, and avoiding very rich or fatty food during the adjustment period all help. These are practical habits rather than a formal protocol, and your prescriber or the Patient Information Leaflet that comes with your pen can give you personalised guidance.

Fatigue is sometimes reported in the first few weeks and usually reflects the body's adjustment alongside a reduced appetite and calorie intake. It is worth flagging to your prescriber if it feels significant or persists, particularly if you are combining treatment with increased physical activity.

Hair thinning, if it occurs, typically appears a few months into treatment as weight loss accelerates. It usually resolves on its own. Ensuring adequate protein intake during treatment is often recommended by dietitians for exactly this reason, though specific nutritional targets are a clinical conversation.

The broader picture: side effects that feel disruptive at week two very often look different by week six. Persistence through the adjustment period is part of the clinical plan, but always within limits your prescriber sets.

When should you get medical help?

Most side effects of Mounjaro are self-limiting, but some warrant prompt medical attention. The MHRA's Drug Safety Update from January 2026 specifically highlighted acute pancreatitis as a known, infrequent but potentially serious effect of GLP-1 receptor agonist medicines. The signal to act: severe, persistent stomach pain that radiates toward the back, with or without vomiting. This is not typical indigestion. Stop your injection and seek urgent medical assessment.

Other situations that need a call to your GP or 111 promptly: signs of gallbladder problems (sharp pain in the upper right abdomen, especially after eating, sometimes with fever or yellowing of the skin); symptoms suggesting significant dehydration from prolonged vomiting or diarrhoea (dizziness on standing, very dark urine, inability to keep fluids down); or any signs of a serious allergic reaction such as throat tightening, widespread rash, or swelling of the face or lips. Our page on what each side effect of Mounjaro involves can help you recognise which symptoms fall into which category.

Low mood and changes in mental wellbeing are worth monitoring too. While the evidence is still developing, it is sensible to report any significant shift in mood or thoughts to your prescriber. Our guide to Mounjaro and mood covers what is currently known.

For any suspected side effect, the MHRA Yellow Card scheme lets patients report directly. It is a valuable part of post-marketing surveillance for a Black Triangle medicine, and reporting even minor effects you are unsure about genuinely contributes to the evidence base.

How does a prescriber weigh up the side-effect risk for you personally?

The BNF and SmPC list population-level frequencies. What they cannot do is apply that information to your medical history, your current medications, your kidney function, or your previous experiences with GI illness. That is the prescriber's job. Certain conditions (a personal or family history of medullary thyroid carcinoma, previous pancreatitis, or significant gastroparesis) change the risk calculation materially. So does a medication list that includes other drugs affecting gastric emptying or oral contraceptives, where tirzepatide's slowing effect on absorption can reduce pill efficacy during the first four weeks at each dose level.

A thorough consultation is not a formality before a click-to-buy. It is the mechanism by which the side-effect profile in a reference text becomes a considered clinical judgement for a specific person. Some people who look like good candidates on paper have contraindications that only emerge in a detailed review. Others who are anxious about the list of GI effects discover that, with the right starting approach, the reality is much gentler than the literature suggests, and our page on why some people experience no side effects on Mounjaro explores the factors that influence individual tolerance. Our page covering the 5 Mounjaro side effects most commonly reported by patients is also a useful starting point for understanding what to watch for.

If you want to explore whether Mounjaro is clinically appropriate for you, our prescribers cover the side-effect picture as a central part of the assessment, not a postscript. You can read a fuller breakdown of the reported effects and what they mean in practice on our Mounjaro side effects overview, or explore weight-loss treatment options more broadly. Details about nume's clinical team are on the clinical team page. Start your free consultation and a GPhC-registered prescriber will review your answers the same day.